EUVIMEDEUVIMED entdecken
Crossref

Stromal Reprogramming Optimizes KRAS-Specific Chemotherapy Inducing Antitumor Immunity in Pancreatic Cancer

Qinglian Hu iD, Jiayu Feng, Lulu Qi, Yuanxiang Jin iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c10404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Qinglian Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Proto-Oncogene Proteins p21(ras), Tumor Microenvironment, Deoxycytidine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsProto-Oncogene Proteins p21(ras)Tumor MicroenvironmentDeoxycytidineGemcitabineCarcinoma, Pancreatic DuctalAnimalsMiceHumansCell Line, TumorPyridonesAntineoplastic AgentsLiposomesCell ProliferationMice, Inbred C57BLPancreatic Stellate Cells

Stichwörter der Autor:innen

KRAS signaling pathwayextracellular matriximmunogenic cell deathnanoengineered liposomespancreatic cancer therapy

Substanzen

Proto-Oncogene Proteins p21(ras)DeoxycytidineKRAS protein, humanGemcitabinePyridonesAntineoplastic AgentspirfenidoneLiposomes

Autor:innen und Institutionen

  • College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China.

ORCID-Profile: Qinglian Hu, Yuanxiang Jin

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Hu, Q., Feng, J., Qi, L., & Jin, Y. (2024). Stromal Reprogramming Optimizes KRAS-Specific Chemotherapy Inducing Antitumor Immunity in Pancreatic Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c10404

Vancouver

Hu Q, Feng J, Qi L, Jin Y. Stromal Reprogramming Optimizes KRAS-Specific Chemotherapy Inducing Antitumor Immunity in Pancreatic Cancer. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c10404

BibTeX
@article{Hu2024,
  author = {Hu, Qinglian and Feng, Jiayu and Qi, Lulu and Jin, Yuanxiang},
  title = {Stromal Reprogramming Optimizes KRAS-Specific Chemotherapy Inducing Antitumor Immunity in Pancreatic Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c10404}
}
Kostenlos starten →